MiscellaneousCarotid Artery Remodeling in Middle-Aged Women With the Metabolic Syndrome (from the “Progetto ATENA” Study)
Section snippets
Study population
We studied a cohort of 310 middle-aged women living in the area of Naples (southern Italy) participating in the “Progetto ATENA” study.1 The general objective of this project is to investigate the causes of those chronic diseases that have a major impact on the female population. The total study cohort, enrolled within a 4-year period, consisted of 5,062 women aged 30 to 69 years. Potential participants with previous diagnoses of myocardial infarction, stroke, and major cancers were excluded.
Results
Seventy-three subjects (23%) fulfilled the Adult Treatment Panel III criteria for the MS.
Women with the MS were slightly older and had higher levels of serum cholesterol, serum insulin, and thiobarbituric acid–reactive substances (Table 1). The group with the MS had a greater mean IMT (1.24 ± 0.27 vs 1.10 ± 0.20 mm, p < 0.0001) and greater mean values for diameters (7.9 ± 1.0 vs 7.4 ± 0.7 mm, p <0.0001 for external diameter; 6.1 ± 0.8 vs 5.8 ± 0.6 mm, p <0.005 for internal diameter). The
Discussion
Coronary artery disease represents a major cause of death and disability in women. In Mediterranean countries, an increase in its incidence is expected in the years ahead in relation to the profound changes in lifestyle leading to the increased incidence of obesity and associated metabolic alterations.11 In women 30 to 74 years of age who were participants in the Second National Health and Nutrition Examination Survey, the MS carried a twofold risk for coronary artery disease mortality.12
A few
References (21)
Triglyceride determination after enzymatic hydrolysis
- et al.
Evaluation of computerized edge tracking for quantifying IMT of the common carotid artery from B-mode ultrasound images
Atherosclerosis
(1994) - et al.
Metabolic syndrome and coronary angiographic disease progressionthe Women’s Angiographic Vitamin & Estrogen trial
Am Heart J
(2003) - et al.
Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness
J Am Coll Cardiol
(2004) - et al.
Progetto Atena, a study on the etiology of major chronic diseases in womendesign, rationale and objectives
Eur J Epidemiol
(1992) - et al.
Site-specific atherosclerotic plaques in the carotid arteries of middle-aged women from southern Italy. Associations with traditional risk factors and oxidation markers
Stroke
(2001) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)final report
Circulation
(2002)- et al.
Improved reagent for enzymatic determination of serum cholesterol
J Clin Chem Biochem
(1981) - et al.
Cholesterol determination in high-density lipoproteins separated by three different methods
Clin Chem
(1977) - et al.
Intima-media thicknessa new tool for diagnosis and treatment of cardiovascular risk
J Hypertens
(2002)
Cited by (33)
Hypertension: pathophysiology and relevance to the cardiometabolic syndrome
2023, Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic MedicineEffect of metabolic syndrome on the response to arterial injury
2014, Journal of Surgical ResearchCitation Excerpt :These patients present frequently for revascularization due to atherosclerotic occlusive disease [2]. The presence of metabolic syndrome can be correlated with increased carotid intima-media thickness in both men [3] and women [4]. Metabolic syndrome has also been demonstrated to amplify vascular wall thickness and stiffness [5].
Cyclooxygenase-2-derived prostanoids reduce inward arterial remodeling induced by blood flow reduction in old obese Zucker rat mesenteric arteries
2013, Vascular PharmacologyCitation Excerpt :It is defined as an association of three or more of the following risk factors: impaired glucose tolerance or insulin resistance, increased blood pressure, increased plasma triglycerides and/or low HDL cholesterol, obesity, microalbuminuria (Alberti and Zimmet, 1998; Onat, 2011; Prasad et al., 2012). The metabolic syndrome is associated with endothelial dysfunction (Goodwill and Frisbee, 2012; Thomas et al., 2004) and vascular remodeling (Rocic, 2012) leading to arterial wall hypertrophy (Iannuzzi et al., 2005). This vascular dysfunction is most likely involved in the higher incidence of end-organ damage in patients with metabolic syndrome.
Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats
2010, AtherosclerosisCitation Excerpt :These results are in agreement with those reported for canine coronary arteries [25], where COX-2 mediates the production of vasodilator and antithrombogenic PGI2 only under conditions of maximal COX-2 induction, after administration of liposaccharide to induce systemic inflammation [26,28]. Metabolic syndrome is associated with a chronic pro-inflammatory state of the vascular wall leading to vascular remodeling and endothelial dysfunction in systemic arteries [2–4]. The 4 month-old obese Zucker rats used in the present study were obese and exhibited hyperinsulinemia, hypercholesterolemia, hypertriglyceridemia and slight hyperglycemia, although at this age they had not yet developed hypertension [4].
Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting
2010, Journal of Vascular SurgeryMetabolic syndrome: A predictor of adverse outcomes after carotid revascularization
2009, Journal of Vascular Surgery
The “Progetto Atena” study was supported by funds from Consiglio Nazionale delle Ricerche, Rome, Italy; “Progetto Finalizzato Biotecnologie” and “Progetto Finalizzato FATMA”; Ministero dell’ Universita’ e Della Ricerca Scientifica e Tecnologica, Rome, Italy; MURST 1998, no. 9806174392-008, and MIUR 2002, no. 0655949-004; and Compagnia di San Paolo, Turin, Italy.